StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
VICP

Vicapsys Life Sciences, Inc.

VICP Pharmaceutical Preparations EDGAR ↗
$1.45
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$49.8M
Revenue (TTM)
Net income (TTM)
-$1.35M
EPS (TTM)
$-0.04
P/E ratio
Dividend yield
Free cash flow
Cash
$89.6K
Total assets
$89.6K
Gross margin
52-week range
$0.15 – $1.77

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2024-09-30 Jan 10, 2025 10-Q Quarter ended 2024-06-30 Jan 10, 2025 10-Q Quarter ended 2024-03-31 Jan 10, 2025 10-K Fiscal year ended 2023-12-31 Oct 21, 2024 8-K Entered a material agreement; Took on a direct financial obligation Dec 27, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 30, 2023 8-K Entered a material agreement Jun 2, 2023 8-K/A Changed accountants May 18, 2023 8-K Changed accountants May 17, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 10-K Fiscal year ended 2022-12-31 Apr 14, 2023 8-K Director or officer change Jan 12, 2023 10-Q Quarter ended 2022-09-30 Nov 21, 2022 8-K Director or officer change Sep 28, 2022 10-Q Quarter ended 2022-06-30 Aug 16, 2022 10-Q Quarter ended 2022-03-31 May 13, 2022 8-K Director or officer change; Other events Apr 12, 2022 10-K Fiscal year ended 2021-12-31 Mar 16, 2022 10-Q Quarter ended 2021-09-30 Nov 12, 2021 10-Q Quarter ended 2021-06-30 Sep 20, 2021 10-Q Quarter ended 2021-03-31 Sep 20, 2021 10-K Fiscal year ended 2020-12-31 Sep 17, 2021 10-Q Quarter ended 2020-09-30 Sep 13, 2021 10-Q Quarter ended 2020-06-30 Sep 9, 2021 10-Q Quarter ended 2020-03-31 May 15, 2020 10-Q Quarter ended 2010-06-30 Aug 24, 2010 8-K/A Completed an acquisition or disposition Jul 29, 2010 8-K Director or officer change Jul 1, 2010 10-Q Quarter ended 2010-03-31 Jun 22, 2010 10-K Fiscal year ended 2009-12-31 May 24, 2010 8-K Completed an acquisition or disposition; Unregistered sale of equity May 18, 2010 8-K Terminated a material agreement; Director or officer change Apr 26, 2010 8-K Director or officer change Apr 12, 2010 8-K Other events Dec 9, 2009
Other filings
15-12G Mar 27, 2025 SCHEDULE 13G Mar 21, 2025 3 Mar 21, 2025 SEC STAFF ACTION Jun 27, 2024